Teva closes in on sale of API business TAPI
The pharma company’s plan to divest its active pharmaceutical ingredient…
The pharma company’s plan to divest its active pharmaceutical ingredient interests was first announced in 2024.
List view / Grid view
The pharma company’s plan to divest its active pharmaceutical ingredient…
The pharma company’s plan to divest its active pharmaceutical ingredient interests was first announced in 2024.
The new Executive Vice President of Teva Global Operations will…
The new Executive Vice President of Teva Global Operations will bring “significant experience at every stage of the manufacturing and supply process” to his new role, the company asserted.
Sandoz has announced that the FDA has approved and launch…
Sandoz has announced that the FDA has approved and launch of Glatopa as a fully-substitutable, AP-rated generic version of Copaxone for relapsing forms of MS...